As AMR deaths are projected to exceed 10 million annually by 2050, there is an urgent need to tackle this silent epidemic ...

New research shows how glucose restriction in tumors protects cancer cells from chemotherapy by preserving pyrimidines and preventing apoptosis, offering insights into treatment strategies.

A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

Fungal infections in patients undergoing cancer treatment present a considerable clinical hurdle due to their weakened immune ...

With ponatinib (Iclusig) receiving an accelerated approval from the FDA earlier this year for the treatment of Philadelphia ...

A recent study from the Centre for Genomic Regulation (CRG) in Barcelona reveals that bacteria can adapt their ribosomes when ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Discover how cancer cells survive in low-glucose environments and evade chemotherapy-induced death. New study sheds light on ...

Millions of people around the world are diagnosed with cancer each year. The rapid proliferation of mutated cells can fatally ...

A new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.

A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...